AU2023221972A1 - Modified release valproic acid softgel capsule - Google Patents

Modified release valproic acid softgel capsule Download PDF

Info

Publication number
AU2023221972A1
AU2023221972A1 AU2023221972A AU2023221972A AU2023221972A1 AU 2023221972 A1 AU2023221972 A1 AU 2023221972A1 AU 2023221972 A AU2023221972 A AU 2023221972A AU 2023221972 A AU2023221972 A AU 2023221972A AU 2023221972 A1 AU2023221972 A1 AU 2023221972A1
Authority
AU
Australia
Prior art keywords
months
softgel capsule
minutes
softgel
proceeding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023221972A
Other languages
English (en)
Inventor
Qi Fang
Karunakar Sukuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of AU2023221972A1 publication Critical patent/AU2023221972A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2023221972A 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule Pending AU2023221972A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263311559P 2022-02-18 2022-02-18
US63/311,559 2022-02-18
PCT/US2023/013277 WO2023158777A1 (en) 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule

Publications (1)

Publication Number Publication Date
AU2023221972A1 true AU2023221972A1 (en) 2024-09-19

Family

ID=87579078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023221972A Pending AU2023221972A1 (en) 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule

Country Status (12)

Country Link
US (1) US20250177312A1 (https=)
EP (1) EP4479033A4 (https=)
JP (1) JP2025506678A (https=)
KR (1) KR20240145031A (https=)
CN (1) CN118647373A (https=)
AR (1) AR128560A1 (https=)
AU (1) AU2023221972A1 (https=)
CA (1) CA3244352A1 (https=)
CO (1) CO2024012216A2 (https=)
IL (1) IL314788A (https=)
MX (1) MX2024010123A (https=)
WO (1) WO2023158777A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
BR112014010782A2 (pt) * 2011-11-03 2017-06-13 Gtx Inc composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20170312226A1 (en) * 2016-04-28 2017-11-02 Ascent Pharmaceuticals, Inc. Pharmaceutical dosage forms
WO2020247352A1 (en) * 2019-06-03 2020-12-10 R.P. Scherer Technologies, Llc Delayed release softgel capsules
US20220400724A1 (en) * 2019-10-28 2022-12-22 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment
JP2023532180A (ja) * 2020-06-02 2023-07-27 アール．ピー．シェーラー テクノロジーズ，エルエルシー 遅延放出ソフトゲルカプセル

Also Published As

Publication number Publication date
US20250177312A1 (en) 2025-06-05
CO2024012216A2 (es) 2024-09-30
CN118647373A (zh) 2024-09-13
WO2023158777A1 (en) 2023-08-24
JP2025506678A (ja) 2025-03-13
EP4479033A4 (en) 2026-03-04
IL314788A (en) 2024-10-01
AR128560A1 (es) 2024-05-22
KR20240145031A (ko) 2024-10-04
CA3244352A1 (en) 2023-08-24
MX2024010123A (es) 2024-08-27
EP4479033A1 (en) 2024-12-25

Similar Documents

Publication Publication Date Title
JP5213446B2 (ja) ジクロフェナクを含む医薬組成物
ES2316350T3 (es) Capsulas blandas masticables con propiedades mejoradas de administracion y procedimiento para producirlas.
PT1592402E (pt) Dispersão de cristais ou grânulos de substâncias ativas com o sabor mascarado, cápsulas moles mastigáveis cheias com a referida dispersão e processo para a preparação dos mesmos
KR20100135316A (ko) 감칠맛을 가진 디페리프론용 액상 제제
JP7793703B2 (ja) ミニソフトゲルナプロキセン組成物
Vaidya et al. Oral fast dissolving drug delivery system: A modern approach for patient compliance
EP4479033A1 (en) Modified release valproic acid softgel capsule
HK40116915A (zh) 改性释放的丙戊酸软明胶胶囊
US20230414523A1 (en) Enteric bisacodyl softgel capsule
US20060233873A1 (en) Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
HK40115360A (zh) 肠溶比沙可啶软凝胶胶囊
EP4121164A1 (en) Medicated cannabinoid compositions, methods of manufacturing, and methods of treatment
KR20260020112A (ko) 암브록솔 액체 제형
WO2025042688A2 (en) Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen
AU2024329567A1 (en) Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen
US20250152523A1 (en) Compositions for treatment of sexual dysfunction
WO2013174884A1 (en) Capsules having an incorporated taste modifying component
HK1082659B (en) Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same